Rankings
▼
Calendar
NUVB Q4 2025 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$42M
+633.1% YoY
Gross Profit
$41M
99.0% margin
Operating Income
-$34M
-81.3% margin
Net Income
-$37M
-87.4% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
+219.1%
Cash Flow
Operating Cash Flow
$144M
Free Cash Flow
$144M
Stock-Based Comp.
-$28M
Balance Sheet
Total Assets
$595M
Total Liabilities
$289M
Stockholders' Equity
$306M
Cash & Equivalents
$164M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$42M
$6M
+633.1%
Gross Profit
$41M
$1M
+2672.0%
Operating Income
-$34M
-$54M
+36.9%
Net Income
-$37M
-$49M
+26.0%
Revenue Segments
License
$35M
60%
Product
$23M
40%
Geographic Segments
JAPAN
$28M
52%
UNITED STATES
$23M
43%
CHINA
$3M
6%
← FY 2025
All Quarters